Post-doc position (m/f/d) in Endocrine Oncology with focus on immunotherapy

Application deadline: 06/06/2026

A postdoctoral position (German TV-L 13, 100%) for two years (with option of prolongation) is available starting 1 July 2026 at the Dept. of Endocrinology of the University Hospital Würzburg. The successful candidate will become member of our interdisciplinary research group developing an advanced gene-engineered immune cell therapy against adrenocortical carcinoma. Our team is embedded in an excellent scientific environment within the framework of an interdisciplinary DFG-funded transregional collaborative research center (https://adrenal-research.de) with additional support of the Nefkens Adrenal Cancer Foundation (https://www.nac.foundation/).  

We have developed a CAR T cell program against adrenocortical carcinoma, which is now already in the stage of transfer to the clinic. Our phase 1 trial started im summer 2025. In this research project, we will improve this immunotherapeutical approach. The ambition is to develop a combinatorial CAR-T cell and CAR-macrophage immune cell product, where the CAR constructs are customized to support the activity of T cells and macrophages, respectively.

More about our previous research can be found by reading our publications (e.g. Landwehr et al. J Clin Endocrinol Metab. 2024; doi: 10.1210/clinem/dgae109. Landwehr et al. J Immunother Cancer. 2020; doi: 10.1136/jitc-2019-000469. Remde et al. doi: Eur J Endocrinol; 2023 10.1093/ejendo/lvad054. Altieri et al. ESMO Open. 2026; doi: 10.1016/j.esmoop.2025.106030 or https://pubmed.ncbi.nlm.nih.gov/?term=fassnacht-m).

• An excellent scientific environment within the framework of an interdisciplinary DFG-funded transregional collaborative research center
  
• Close interaction with the Chair of Cellular Immunotherapy (https://www.ukw.de/medizinische-klinik-ii/lehrstuhl-fuer-zellulaere-immuntherapie/team/ of Prof. Dr. Michael Hudecek)
  
• Projects on the forefront of translational research and prospects for clinical translation
  
• Attractive salary according to TV-L including annual special payment: We value your work and reward you with a fair and competitive salary.
  
• Institutional pension scheme: We support your financial security in retirement.
  
• Flexitime: Allows you to organize your working hours flexibly.
  
• Comprehenssive institutional sports programs including our own gym (Milon circuit training) helps you stay fit and healthy.
  
• Own institutional day-care center for your children with extended opening hours (5:30 – 18:00): To help you better balance work and family.
• Extensive training and further education at our own academy: We promote your personal and professional development.
  
• A demanding, diverse and capable of development working program
  
• A good working atmosphere in a highly motivated and collegial team
  
• The University Hospital of Würzburg promotes gender equality
  
• Severely disabled applicants with equal qualifications will be given preferential consideration

• Independent scientific work within the scope of the above-mentioned research project
• Planning, conducting, and evaluating cell biology, molecular biology, and (animal experimentation) studies
• Application of modern immunotherapy and gene editing technologies (including CAR-T, CAR macrophages, CRISPR/Cas9)
• Presentation of results at scientific conferences and publication in scientific journals

• Excellent PhD degree in tumor immunology, cell therapy, and translational cancer research
• Extenssive experience in molecular or cell biology methods
• Highly motivated, able to work independently and as part of a team
• Very good written and spoken English skills

• Challenging, diverse and evolving area of responsibility
• Attractive salary according to TV-L incl. annual special payment
• Training and Continuing Education
• Retirement Pension Plan
• Company daycare center with extended opening hours
• Company sports program
• Flexible Working Hours
• JobBike
• Corporate Benefits